Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Physiological Reports, 2022
Quantifying the inflammatory secretome of human intermuscular adipose tissue

Kahn D., Macias E., Zarini S. et al.

Olink Target 96Metabolic DiseasesPathophysiologyCell Culture Supernatant

Scientific Reports, 2022
Association of extracellular vesicle inflammatory proteins and mortality

Noren Hooten N., Torres S., Mode N. et al.

Olink Target 96Wider Proteomics StudiesPatient StratificationEV Lysate

International Journal of Molecular Sciences, 2022
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery

Beltrami A., De Martino M., Dalla E. et al.

Olink Target 96Infectious DiseasesPatient StratificationSerum

Nordic Journal of Psychiatry, 2022
Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy

Thörnblom E., Gingnell M., Cunningham J. et al.

Olink Target 96NeurologyPathophysiologySerum

Nature Cardiovascular Research, 2022
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension

Boucherat O., Yokokawa T., Krishna V. et al.

Olink Explore 3072/384CVDPathophysiologyPatient StratificationPlasma

American Heart Journal Plus: Cardiology Research and Practice, 2022
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension

Helleberg S., Engel A., Ahmed S. et al.

Olink Target 96CVDPatient StratificationPlasma

Fluids and Barriers of the CNS, 2022
Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters

Lolansen S., Rostgaard N., Barbuskaite D. et al.

Olink Target 96NeurologyPathophysiologyCSF

PROTEOMICS – Clinical Applications, 2022
Plasma biomarkers for systemic inflammation in COVID‐19 survivors

Zhao J., Schank M., Wang L. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Rheumatology, 2022
Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression

Szilagyi I., Vallerga C., Boer C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Diabetologia, 2022
Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality

Bao X., Xu B., Muhammad I. et al.

Olink Target 96OncologyMetabolic DiseasesPatient StratificationPlasma

Laboratory Investigation, 2022
High-throughput proteomics: a methodological mini-review

Cui M., Cheng C., Zhang L.

Wider Proteomics StudiesReview/editorial

Frontiers in Cardiovascular Medicine, 2022
Increased inflammatory markers in adult patients born with an atrial septal defect

Schram A., Sellmer A., Nyboe C. et al.

Olink Target 96CVDPathophysiologySerum

Nature Communications, 2022
Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity

Deaton A., Dubey A., Ward L. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Frontiers in Immunology, 2022
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy

Papapavlou Lingehed G., Hellberg S., Huang J. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Frontiers in Immunology, 2022
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa

Petkov S., Herrera C., Else L. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Cardiovascular Research, 2022
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation

Pol, T., Hijazi et al.

Olink Target 96CVDPathophysiologyPlasma

Clinical Lymphoma Myeloma and Leukemia, 2022
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments

Fernandez N., Perumal D., Rahman A. et al.

OncologyPathophysiologyPatient Stratification

Molecular Oncology, 2022
Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome

Viktorsson K., Hååg P., Shah C. et al.

Olink Target 96OncologyPatient StratificationPlasmaEV Lysate

International Immunopharmacology, 2022
Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease

Mi J., Liu Z., Pei S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Clinical Cancer Research, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19

Diorio C., Shraim R., Myers R. et al.

Olink Explore 3072/384OncologyImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

3144 publications